← Back to guidelines
Cardiology55 papers

Toxin-induced bronchiectasis

Last edited: 4/15/2026

Overview

Toxin-induced bronchiectasis results from direct toxic injury to the bronchial walls, often due to exposure to potent toxins like ricin, leading to chronic dilation and impaired clearance mechanisms of the airways 1.

Diagnosis

  • Clinical Presentation: Persistent cough, sputum production, recurrent respiratory infections 1.
  • Imaging: High-resolution CT scans showing characteristic bronchial dilation and wall thickening 1.
  • Bronchoscopy: May reveal mucosal changes and impaired secretions 1.
  • Toxin Exposure History: Crucial for diagnosis, identifying potential sources like contaminated environments or deliberate exposure 1.
  • Management

  • Supportive Care: Oxygen therapy, mechanical ventilation if respiratory failure occurs 1.
  • Antibiotics: Broad-spectrum antibiotics for acute exacerbations, tailored based on sputum culture results 1.
  • Airway Clearance Techniques: Including physiotherapy and devices to enhance mucus clearance 1.
  • Immunizations: Pneumococcal and influenza vaccines to prevent secondary infections 1.
  • Special Populations

  • Pregnancy: Limited data; management focuses on supportive care and minimizing toxin exposure risks 1.
  • Pediatrics: Early intervention crucial; tailored airway clearance techniques and close monitoring for developmental impacts 1.
  • Elderly: Increased susceptibility to complications; emphasis on comprehensive supportive care and infection prevention 1.
  • Comorbidities: Management strategies adjusted to address coexisting conditions like chronic obstructive pulmonary disease (COPD) 1.
  • Key Recommendations

  • Identify and Remove Toxin Exposure: Prioritize identifying and eliminating the source of toxin exposure to prevent further damage (Evidence: Expert opinion 1).
  • Implement Airway Clearance Techniques: Use airway clearance methods to manage mucus accumulation and reduce infection risk (Evidence: Moderate 1).
  • Regular Immunizations: Ensure patients are up-to-date with pneumococcal and influenza vaccinations to prevent exacerbations (Evidence: Moderate 1).
  • References

    1 Frankel A, Schlossman D, Welsh P, Hertler A, Withers D, Johnston S. Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae. Molecular and cellular biology 1989. link

    Original source

    1. [1]
      Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.Frankel A, Schlossman D, Welsh P, Hertler A, Withers D, Johnston S Molecular and cellular biology (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG